Johnson and Johnson&#39;s CEO and chairman Alex Gorsky said in a statement that the acquisition of Actelion, a leader in medicines treating high blood pressure, offered &quot;compelling value&quot; to shareholders in both companies. 
&nbsp;

Johnson and Johnson says to buy pharma group Actelion for $30 bn

Nongluck is a senior economic journalist covering the macroeconomics, real estate, and corporate investment strategies driving growth across Thailand and Southeast Asia.

AI Can't Make Whisky: Business Chiefs on Keeping the Human Touch at Work

DDPM warns 2 Thai provinces of flash floods on October 15

Nuttapakron is a Rewriter for Nation Group. He focuses on factual precision and clarity, striving to present updates that are both trustworthy and highly readable.&nbsp;

Johnson and Johnson says to buy pharma group Actelion for $30 bn

ZURICH - US pharmaceuticals giant Johnson and Johnson on Thursday announced it was buying Swiss medical firm Actelion for $30 billion (27.9 billion euros).

'Speeding' motorcycle rider plunges 6 metres down hole on Thonburi road

Military trucks on standby at 11 Bangkok districts to transport commuters

Constitutional Court chief orders probe into ‘leak’ of witness’ statement